On November 5, 2026, Gelteq is trading 6.7% lower at $0.43, with no confirmed company-specific news explaining the intraday decline.
- A November 2 SEC notice said the company needed more time to complete its annual report and expected to file within the permitted 15-day grace period; available sources do not establish the notice as the cause.
- Biotechnology rose 2.05%, so the decline does not align with that sector move. The reason remains uncertain.